Industry: Pharmaceuticals, Biotechnology
Errant Gene Therapeutics, LLCÔ was established in October 2003 by Patrick Girondi and Norbert L. Wiech, Ph.D. to develop treatments for life-threatening diseases, in particular those recognized as rare disorders or orphan diseases. Its founders share a common vision and dedication for the science and business strategy of orphan drug product development. Both founders have been involved with orphan drug discovery and development for more than fifteen years. Their experience is the foundation for the success of the company. EGT’s primary strategy is to address the unmet medical needs of patients with orphan diseases through the development of its technology and ( www.errantgene.com )
Errant Gene Therapeutics LLC
218 North Jefferson Street Suite 300
Chicago, Illinois 60661
USA
Tel: (312) 441-1800
Fax: (312) 893-2200